TrialJournal of the American Heart Association2023

Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results.

Andrea L Vavere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.